We are live on ! Find out more
AHPI

Allied Healthcare Products
AHPI

Delisted

AHPI was delisted on the 2nd of February, 2023.

Back to rankings

12 hedge funds and large institutions have $220K invested in Allied Healthcare Products in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

47% less capital invested

Capital invested by funds: $414K → $220K (-$194K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TDC
Thompson Davis & Co
Virginia
+$5.51K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.34K
3
Citigroup
Citigroup
New York
+$129

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$42.1K
2
Renaissance Technologies
Renaissance Technologies
New York
-$29.9K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$29.3K
4
Millennium Management
Millennium Management
New York
-$25K
5
HF
HRT Financial
New York
-$24K

AHPI Hedge Fund Activity: Q3 2022 in Review

12 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2022, worth a combined $220K — down 47% from $414K a quarter earlier.

Fund positioning in AHPI was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 5 trimmed.

The largest buyer was Thompson Davis & Co, adding an estimated $5.51K. The largest seller was Vanguard Group, cutting an estimated $42.1K.

  • 12 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $220K of Allied Healthcare Products stock for Q3 2022, down 47% quarter-over-quarter.
  • 2 funds opened new Allied Healthcare Products positions in Q3 2022 and 2 closed out, a net change of 0 holders.
  • The largest Allied Healthcare Products buyer in Q3 2022 was Thompson Davis & Co, an estimated $5.51K added.
  • The largest Allied Healthcare Products seller in Q3 2022 was Vanguard Group, an estimated $42.1K sold.

Based on aggregated 13F filings for Q3 2022.